UltraFLEXplus Surge Confirms AI Test Demand, but Valuation Leaves Little Room for Error

What happened

Teradyne's UltraFLEXplus shipments more than doubled over the past nine months, underscoring AI-driven chip test demand that powered a record 1Q26. However, the DeepValue report flags that management's AI dominance language only explicitly covers the next quarter, and the stock's P/E of 62 embeds an extended AI cycle. The near-term catalyst—merchant GPU production in Q2'26—has not yet been confirmed, and failure to deliver could reset expectations. Meanwhile, adjacencies like Product Test remain small at $80 million quarterly, limiting diversification. The strong order momentum is real, but the market is paying for perfection that has yet to be proven beyond the current quarter.

Implication

The UltraFLEXplus momentum validates the AI test narrative, but investors should demand proof of durability beyond Q2'26. A pullback toward $280 would offer a better entry with a margin of safety, while clear AI language extension and GPU production could drive upside toward $420.

Thesis delta

The article reinforces the existing thesis that AI test demand is robust in the near term, but it does not resolve the key uncertainty around sustainability. The new data on UltraFLEXplus doubling supports the base case but does not shift the judgment from WAIT, as valuation already reflects this strength.